Biggest News Aggregation in the World
📰 Seth Lederman News

Seth Lederman News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Seth Lederman. Real-time updates on events, politics, business and more.

Tonix Pharmaceuticals Reports Improvement in "Brain Fog," in Fibromyalgia Patients Treated with Tonmya in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia Seite 1

11.03.2024 - Phase 3 RESILIENT study of Tonmya met its primary endpoint of daily pain reduction (p=0.00005) and achieved statistically significant improvement on all six key pre-specified secondary endpoints with effect sizes on sleep, fatigue, FIQ-R symptoms ... Seite 1
Bruxelles Capitale Seth Lederman Tonix Pharmaceuticals Holding Corp Tonix Pharmaceuticals International Congress On Controversies In Fibromyalgia Pharmaceuticals Holding

Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in Fibromyalgia

Additional data from recently reported positive Phase 3 RESILIENT trial will be presentedCHATHAM, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that Seth Lederman, M.D., Chief Executive Officer, will present at The 6th International Congress on Controversies in Fibromyalgia in Brussels, Belgium on March 7, 2024. The pres
Bruxelles Capitale Ben Shannon Seth Lederman Jessica Morris Peter Vozzo Zembrace Symtouch
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Tonix Pharma Plans Regulatory Filings For Tonmya In Japan, China, US; Stock Up

Tonix Pharmaceuticals Holding Corp. (TNXP), Tuesday announced that it is planning for regulatory filings in Japan, China and the U.S., following the positive results from its clinical pharmacokinetic bridging study of Tonmya.
Seth Lederman Tonix Pharmaceuticals Holding Corp Drug Administration Tonix Pharmaceuticals Holding Clinical Trial Notification Investigational New Drug

Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya to Support Development and Partnering in Japan and China

27.02.2024 - Tonix plans to File a Clinical Trial Notification (CTN) in Japan and Investigational New Drug (IND) application in China to support a registration-enabling Asian Phase 3 study without dosage adjustment based on U.S. registrational Phase 3 data ... Seite 1
Hong Kong Seth Lederman Tonix Pharmaceuticals Holding Corp Tonix Pharmaceuticals New Drug Application Pharmaceuticals Holding

Tonix Pharma Plans Regulatory Filings For Tonmya In Japan, China, US; Stock Up

Tonix Pharmaceuticals Holding Corp. (TNXP), Tuesday announced that it is planning for regulatory filings in Japan, China and the U.S., following the positive results from its clinical pharmacokinetic bridging study of Tonmya.
Seth Lederman Drug Administration Tonix Pharmaceuticals Holding Corp Tonix Pharmaceuticals Holding Clinical Trial Notification Investigational New Drug

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science